Clodi, Martin; Abrahamian, Heidemarie; Brath, Helmut; Brix, Johanna; Drexel, Heinz; Fasching, Peter; Föger, Bernhard; Francesconi, Claudia; Fröhlich-Reiterer, Elke; Harreiter, Jürgen; Hofer, Sabine E; Hoppichler, Friedrich; Huber, Joakim; Kaser, Susanne; Kautzky-Willer, Alexandra; Lechleitner, Monika; Ludvik, Bernhard; Luger, Anton; Mader, Julia K; Paulweber, Bernhard; ... (2019). [Antihyperglycemic treatment guidelines for diabetes mellitus type 2 (Update 2019)]. Wiener klinische Wochenschrift, 131(Suppl 1), pp. 27-38. Springer-Verlag 10.1007/s00508-019-1471-z
|
Text
ClodiM_AntihyperglykämischeTherapie_WienKlinWochenschr.pdf - Published Version Available under License Creative Commons: Attribution (CC-BY). Download (511kB) | Preview |
Hyperglycemia significantly contributes to complications in patients with diabetes mellitus. While lifestyle interventions remain cornerstones of disease prevention and treatment, most patients with type 2 diabetes will eventually require pharmacotherapy for glycemic control. The definition of individual _targets regarding optimal therapeutic efficacy and safety as well as cardiovascular effects is of great importance. In this guideline we present the most current evidence-based best clinical practice data for healthcare professionals.
Item Type: |
Journal Article (Review Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Angiology |
UniBE Contributor: |
Drexel, Heinz |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
0043-5325 |
Publisher: |
Springer-Verlag |
Language: |
German |
Submitter: |
Isabel Lorenz |
Date Deposited: |
13 Dec 2019 09:27 |
Last Modified: |
05 Dec 2022 15:33 |
Publisher DOI: |
10.1007/s00508-019-1471-z |
PubMed ID: |
30980148 |
Uncontrolled Keywords: |
Diabetes mellitus Type 2 Glucose lowering Therapy |
BORIS DOI: |
10.7892/boris.136390 |
URI: |
https://boris.unibe.ch/id/eprint/136390 |
Actions (login required)
 |
Edit item |